Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis

Pediatric Research

Volumn 71, Issue 1, 2012, Pages 4-12

  Wouthuyzen Bakker, Marjan ^a   Bijvelds, Marcel J C ^b   De Jonge, Hugo R ^b   De Lisle, Robert C ^c   Burgerhof, Johannes G M ^d   Verkade, Henkjan J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BILE SALT; CHOLIC ACID; CIPROFLOXACIN; FATTY ACID; ISOTOPE; METRONIDAZOLE; RADIOPHARMACEUTICAL AGENT; STEARIC ACID C 13; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRIPALMITIN C 13; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIUM; BILE; BODY FAT; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; FECES; FEMALE; GAS CHROMATOGRAPHY; HEPATOBILIARY SYSTEM; INTESTINE FLORA; ISOTOPE LABELING; KINETICS; LIPID ABSORPTION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SMALL INTESTINE; SOLUBILIZATION; TREATMENT OUTCOME; WILD TYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; BILE ACIDS AND SALTS; BODY WEIGHT; CIPROFLOXACIN; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIETARY FATS; DISEASE MODELS, ANIMAL; FECES; FEMALE; HUMANS; INTESTINAL ABSORPTION; METRONIDAZOLE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 83655182977     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2011.4     Document Type: Article

References (28)

1. Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002;1:51-75.
2. Borowitz D, Durie PR, Clarke LL, et al. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr 2005;41: 273-85. (Pubitemid 41285817)
3. Saiman L, Anstead M, Mayer-Hamblett N, et al.; AZ0004 Azithromycin Study Group. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2010;303:1707-15.
4. Saiman L, Marshall BC, Mayer-Hamblett N, et al.; Macrolide Study Group. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003;290:1749-56. (Pubitemid 37430625)
5. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 2004;72:6040-9. (Pubitemid 39303719)
6. Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008;43:1030-7.
7. Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, Verkade HJ. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am J Physiol Gastrointest Liver Physiol 2005;288:G646-53. (Pubitemid 40388175)
8. Martin FP, Dumas ME, Wang Y, et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol 2007;3:112.
9. Savage DC, Dubos R. Alterations in the mouse cecum and its flora produced by antibacterial drugs. J Exp Med 1968;128:97-110.
10. Strandvik B, Einarsson K, Lindblad A, Angelin B. Bile acid kinetics and biliary lipid composition in cystic fibrosis. J Hepatol 1996;25:43-8. (Pubitemid 26267091)
11. O'Brien S, Mulcahy H, Fenlon H, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137-41. (Pubitemid 23245371)
12. De Lisle RC, Roach EA, Norkina O. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. J Pediatr Gastroenterol Nutr 2006;42:46-52. (Pubitemid 43061009)
13. De Lisle RC. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2007;293:G104-11. (Pubitemid 47105181)
14. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2004;286:G1032-41. (Pubitemid 38715667)
15. Durie PR, Newth CJ, Forstner GG, Gall DG. Malabsorption of mediumchain triglycerides in infants with cystic fibrosis: correction with pancreatic enzyme supplement. J Pediatr 1980;96:862-4. (Pubitemid 10068215)
16. de Somer P, Eyssen H, Evrard E. The influence of antibiotics on fecal fat in chicks. In: Frazer AC, ed. Biochemical Problems of Lipids. Amsterdam: Elsevier, 1963:84-90.
17. Gonzalez J, Fernandez C, Marino E, Morales A, Jimenez R. Biliary excretion and choleretic effect of cefmetazole in rats. Antimicrob Agents Chemother 1989;33:1970-4. (Pubitemid 19266263)
18. Verkade HJ, van Asselt WA, Vonk RJ, et al. Fat absorption in premature infants: the effect of lard and antibiotics. Eur J Pediatr 1989;149:126-9. (Pubitemid 20000998)
19. Le Dafniet M, Pessayre D, Le Quernec L, Erlinger S. Effects of troleandomycin administration on cholesterol 7 alpha-hydroxylase activity and bile secretion in rats. J Pharmacol Exp Ther 1981;219:558-62. (Pubitemid 12252061)
20. Toda T, Ohi K, Kudo T, et al. Ciprofloxacin suppresses Cyp3a in mouse liver by reducing lithocholic acid-producing intestinal flora. Drug Metab Pharmacokinet 2009;24:201-8.
21. Eklund A, Norman A, Strandvik B. Excretion of bile acids in healthy children and children with cystic fibrosis. Scand J Clin Lab Invest 1980;40:595-608. (Pubitemid 11202827)
22. Muskiet FA, van Doormaal JJ, Martini IA, Wolthers BG, van der Slik W. Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J Chromatogr 1983;278:231-44. (Pubitemid 14218965)
23. Setchell KD, Worthington J. A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges. Clin Chim Acta 1982;125:135-44. (Pubitemid 12002374)
24. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989;30:719-30. (Pubitemid 19144779)
25. Millar JS, Cromley DA, McCoy MG, Rader DJ, Billheimer JT. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J Lipid Res 2005;46:2023-8. (Pubitemid 41248500)
26. Barman M, Unold D, Shifley K, et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 2008;76:907-15. (Pubitemid 351428049)
27. Salzman NH, de Jong H, Paterson Y, Harmsen HJ, Welling GW, Bos NA. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002;148(Pt 11): 3651-60. (Pubitemid 35414474)
28. van der Sluis M, Melis MH, Jonckheere N, et al. The murine Muc2 mucin gene is transcriptionally regulated by the zinc-finger GATA-4 transcription factor in intestinal cells. Biochem Biophys Res Commun 2004;325:952-60. (Pubitemid 39487964)